Received: 25 March 2021
Accepted: 9 November 2021
First Online: 20 November 2021
: Research protocols for the present study were approved by the Institutional Review Board of the Peking University School of Oncology, Beijing, China (approval no. 2011101110). Informed consent was obtained from all individual participants included in the study. All experiments were performed in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors declare that they have no competing interests.